Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1983 Jun;138(6):838–846.

Treatment of Diabetes With Insulin—From Art to Science

Matthew C Riddle
PMCID: PMC1010832  PMID: 6351440

Abstract

Improved understanding of the physiology and pharmacokinetics of insulin and new therapeutic devices allow an increasingly rational approach to the treatment of diabetes with insulin. The complexity of the regimen necessary for successful control of blood glucose levels depends largely on a patient's relative deficiency of endogenous insulin. Patients initially treated successfully with single or twice-a-day injections often, as the amount of endogenous insulin dwindles, progress to a complex regimen more closely mimicking normal patterns of secretion. Self-monitoring of blood glucose values and attention to many simple factors affecting absorption of insulin and glycemic behavior strongly enhance the success of all regimens. Patients and physicians must collaborate to plan and execute individualized therapeutic regimens using available tools to the best advantage.

Full text

PDF
838

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asplin C. M., Hartog M., Goldie D. J. Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin. Diabetologia. 1978 Feb;14(2):99–105. doi: 10.1007/BF01263447. [DOI] [PubMed] [Google Scholar]
  2. BALODIMOS M. C., ROOT H. F. Hypoglycemic insulin reactions without warning symptoms. J Am Med Assoc. 1959 Sep 19;171:261–266. doi: 10.1001/jama.1959.03010210013004. [DOI] [PubMed] [Google Scholar]
  3. Berger M., Cüppers H. J., Hegner H., Jörgens V., Berchtold P. Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care. 1982 Mar-Apr;5(2):77–91. doi: 10.2337/diacare.5.2.77. [DOI] [PubMed] [Google Scholar]
  4. Bernstein R. K. Virtually continuous euglycemia for 5 yr in a labile juvenile-onset diabetic patient under noninvasive closed-loop control. Diabetes Care. 1980 Jan-Feb;3(1):140–143. doi: 10.2337/diacare.3.1.140. [DOI] [PubMed] [Google Scholar]
  5. Blackshear P. J., Rohde T. D., Grotting J. C., Dorman F. D., Perkins P. R., Varco R. L., Buchwald H. Control of blood glucose in experimental diabetes by means of a totally implantable insulin infusion device. Diabetes. 1979 Jul;28(7):634–639. doi: 10.2337/diab.28.7.634. [DOI] [PubMed] [Google Scholar]
  6. Bloom S. R., Adrian T. E., Barnes A. J., Polak J. M. Autoimmunity in diabetics induced by hormonal contaminants of insulin. Lancet. 1979 Jan 6;1(8106):14–17. doi: 10.1016/s0140-6736(79)90455-0. [DOI] [PubMed] [Google Scholar]
  7. Bodansky H. J., Wolf E., Cudworth A. G., Dean B. M., Nineham L. J., Bottazzo G. F., Matthews J. A., Kurtz A. B., Kohner E. M. Genetic and immunologic factors in microvascular disease in type I insulin-dependent diabetes. Diabetes. 1982 Jan;31(1):70–74. doi: 10.2337/diab.31.1.70. [DOI] [PubMed] [Google Scholar]
  8. Brownlee M. Insulin treatment of diabetes. Hosp Pract. 1979 Apr;14(4):85–94. doi: 10.1080/21548331.1979.11707527. [DOI] [PubMed] [Google Scholar]
  9. Cahill G. F., Jr, McDevitt H. O. Insulin-dependent diabetes mellitus: the initial lesion. N Engl J Med. 1981 Jun 11;304(24):1454–1465. doi: 10.1056/NEJM198106113042403. [DOI] [PubMed] [Google Scholar]
  10. Cerasi E., Luft R., Efendić S. Effect of adrenergic blocking agents on insulin response to glucose infusion in man. Acta Endocrinol (Copenh) 1972 Feb;69(2):335–346. doi: 10.1530/acta.0.0690335. [DOI] [PubMed] [Google Scholar]
  11. Champion M. C., Shepherd G. A., Rodger N. W., Dupre J. Continuous subcutaneous infusion of insulin in the management of diabetes mellitus. Diabetes. 1980 Mar;29(3):206–212. doi: 10.2337/diab.29.3.206. [DOI] [PubMed] [Google Scholar]
  12. Charles M. A., Ong K., Slater L., Golden M., Arquilla E. R. Immunologic implications of insulin delivery and the role of immune complexes in diabetic sequelae. Diabetes Care. 1982 May-Jun;5 (Suppl 1):88–92. [PubMed] [Google Scholar]
  13. Clarke W. L., Haymond M. W., Santiago J. V. Overnight basal insulin requirements in fasting insulin-dependent diabetics. Diabetes. 1980 Jan;29(1):78–80. doi: 10.2337/diab.29.1.78. [DOI] [PubMed] [Google Scholar]
  14. Crouch M., Jones A., Kleinbeck E., Reece E., Bessman A. N. Reuse of disposable syringe-needle units in the diabetic patient. Diabetes Care. 1979 Sep-Oct;2(5):418–420. doi: 10.2337/diacare.2.5.418. [DOI] [PubMed] [Google Scholar]
  15. Davidson M. B. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism. 1979 Jun;28(6):688–705. doi: 10.1016/0026-0495(79)90024-6. [DOI] [PubMed] [Google Scholar]
  16. Deckert T. Intermediate-acting insulin preparations: NPH and lente. Diabetes Care. 1980 Sep-Oct;3(5):623–626. doi: 10.2337/diacare.3.5.623. [DOI] [PubMed] [Google Scholar]
  17. Dornan T. L., Peckar C. O., Mayon-White V. A., Knight A. H., Moore R. A., Hockaday T. D., Bron A. J., Turner R. C. Unsuspected hypoglycaemia, haemoglobin A1 and diabetic control. Q J Med. 1981;50(197):31–38. [PubMed] [Google Scholar]
  18. Eaton R. P., Allen R. C., Schade D. S., Standefer J. C. "Normal" insulin secretion: the goal of artificial insulin delivery systems? Diabetes Care. 1980 Mar-Apr;3(2):270–273. [PubMed] [Google Scholar]
  19. Fajans S. S., Floyd J. C., Jr, Knopf R. F., Rull J., Guntsche E. M., Conn J. W. Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man. J Clin Invest. 1966 Apr;45(4):481–492. doi: 10.1172/JCI105362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Field J. B., Rojdmark S., Harding P., Ishida T., Chou M. C. Role of liver in insulin physiology. Diabetes Care. 1980 Mar-Apr;3(2):255–260. doi: 10.2337/diacare.3.2.255. [DOI] [PubMed] [Google Scholar]
  21. Fitz-Patrick D., Patel Y. C. Antibodies to insulin, pancreatic polypeptide, glucagon, and somatostatin in insulin-treated diabetics. J Clin Endocrinol Metab. 1981 May;52(5):948–952. doi: 10.1210/jcem-52-5-948. [DOI] [PubMed] [Google Scholar]
  22. Fuller J. H., Shipley M. J., Rose G., Jarrett R. J., Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet. 1980 Jun 28;1(8183):1373–1376. doi: 10.1016/s0140-6736(80)92651-3. [DOI] [PubMed] [Google Scholar]
  23. Galloway J. A. Insulin treatment for the early 80s: facts and questions about old and new insulins and their usage. Diabetes Care. 1980 Sep-Oct;3(5):615–622. doi: 10.2337/diacare.3.5.615. [DOI] [PubMed] [Google Scholar]
  24. Galloway J. A., Spradlin C. T., Nelson R. L., Wentworth S. M., Davidson J. A., Swarner J. L. Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures. Diabetes Care. 1981 May-Jun;4(3):366–376. doi: 10.2337/diacare.4.3.366. [DOI] [PubMed] [Google Scholar]
  25. Giugliano D., Torella R., Cacciapuoti F., Gentile S., Verza M., Varricchio M. Impairment of insulin secretion in man by nifedipine. Eur J Clin Pharmacol. 1980 Nov;18(5):395–398. doi: 10.1007/BF00636791. [DOI] [PubMed] [Google Scholar]
  26. Gray R. S., Borsey D. Q., Fraser D. M., Kurtz A. B., Rainbow S., Smith A. F., Duncan L. J., Clarke B. F. Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins. Diabetologia. 1981 Sep;21(3):206–210. doi: 10.1007/BF00252655. [DOI] [PubMed] [Google Scholar]
  27. Greenough A., Cockcroft P. M., Bloom A. Disposable syringes for insulin injection. Br Med J. 1979 Jun 2;1(6176):1467–1468. doi: 10.1136/bmj.1.6176.1467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. HALLAS-MOLLER K. The lente insulins. Diabetes. 1956 Jan-Feb;5(1):7–14. doi: 10.2337/diab.5.1.7. [DOI] [PubMed] [Google Scholar]
  29. HALLAS-M|OLLER K., JERSILD M., PETERSEN K., SCHLICHTKRULL J. Zinc insulin preparations for single daily injection; clinical studies of new preparations with prolonged action. J Am Med Assoc. 1952 Dec 27;150(17):1667–1671. doi: 10.1001/jama.1952.03680170021006. [DOI] [PubMed] [Google Scholar]
  30. Hoekstra J. B., van Rijn H. J., Erkelens D. W., Thijssen J. H. C-peptide. Diabetes Care. 1982 Jul-Aug;5(4):438–446. doi: 10.2337/diacare.5.4.438. [DOI] [PubMed] [Google Scholar]
  31. Holman R. R., Turner R. C. Diabetes: The quest for basal normoglycaemia. Lancet. 1977 Feb 26;1(8009):469–474. doi: 10.1016/s0140-6736(77)91954-7. [DOI] [PubMed] [Google Scholar]
  32. Jovanovic L., Peterson C. M. Management of the pregnant, insulin-dependent diabetic woman. Diabetes Care. 1980 Jan-Feb;3(1):63–68. doi: 10.2337/diacare.3.1.63. [DOI] [PubMed] [Google Scholar]
  33. Jovanovic L., Peterson C. M. Optimal insulin delivery for the pregnant diabetic patient. Diabetes Care. 1982 May-Jun;5 (Suppl 1):24–37. [PubMed] [Google Scholar]
  34. Jovanovic L., Peterson C. M. The clinical utility of glycosylated hemoglobin. Am J Med. 1981 Feb;70(2):331–338. doi: 10.1016/0002-9343(81)90770-1. [DOI] [PubMed] [Google Scholar]
  35. Kahn C. R., Rosenthal A. S. Immunologic reactions to insulin: insulin allergy, insulin resistance, and the autoimmune insulin syndrome. Diabetes Care. 1979 May-Jun;2(3):283–295. doi: 10.2337/diacare.2.3.283. [DOI] [PubMed] [Google Scholar]
  36. Koivisto V. A., Felig P. Effects of leg exercise on insulin absorption in diabetic patients. N Engl J Med. 1978 Jan 12;298(2):79–83. doi: 10.1056/NEJM197801122980205. [DOI] [PubMed] [Google Scholar]
  37. Koivisto V. A., Fortney S., Hendler R., Felig P. A rise in ambient temperature augments insulin absorption in diabetic patients. Metabolism. 1981 Apr;30(4):402–405. doi: 10.1016/0026-0495(81)90122-0. [DOI] [PubMed] [Google Scholar]
  38. Levandoski L. A., White N. H., Santiago J. V. Localized skin reactions to insulin: insulin lipodystrophies and skin reactions to pumped subcutaneous insulin therapy. Diabetes Care. 1982 May-Jun;5 (Suppl 1):6–10. [PubMed] [Google Scholar]
  39. Lock D. R., Rigg L. A. Hypoglycemic coma associated with subcutaneous insulin infusion by portable pump. Diabetes Care. 1981 May-Jun;4(3):389–391. doi: 10.2337/diacare.4.3.389. [DOI] [PubMed] [Google Scholar]
  40. Lutterman J. A., Benraad T. J., van 't Laar A. The relationship between residual insulin secretion and metabolic stability in type 1 (insulin dependent) diabetes. Diabetologia. 1981 Aug;21(2):99–102. doi: 10.1007/BF00251274. [DOI] [PubMed] [Google Scholar]
  41. Madsbad S., Krarup T., McNair P., Christiansen C., Faber O. K., Transbøl I., Binder C. Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand. 1981;210(3):153–156. doi: 10.1111/j.0954-6820.1981.tb09793.x. [DOI] [PubMed] [Google Scholar]
  42. Malherbe C., Burrill K. C., Levin S. R., Karam J. H., Forsham P. H. Effect of diphenylhydantoin on insulin secretion in man. N Engl J Med. 1972 Feb 17;286(7):339–342. doi: 10.1056/NEJM197202172860702. [DOI] [PubMed] [Google Scholar]
  43. Mirouze J., Selam J. L., Pham T. C., Mendoza E., Orsetti A. Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas. Diabetologia. 1978 Apr;14(4):223–227. doi: 10.1007/BF01219420. [DOI] [PubMed] [Google Scholar]
  44. Nathan D. M., Lou P., Avruch J. Intensive conventional and insulin pump therapies in adult type I diabetes. A crossover study. Ann Intern Med. 1982 Jul;97(1):31–36. doi: 10.7326/0003-4819-97-1-31. [DOI] [PubMed] [Google Scholar]
  45. Nelson J. D., Zinman B., Marliss E. B. Multiple daily s.c. insulin doses. Diabetes Care. 1980 Nov-Dec;3(6):704–705. doi: 10.2337/diacare.3.6.704. [DOI] [PubMed] [Google Scholar]
  46. Oakley W., Hill D., Oakley N. Combined use of regular and crystalline protamine (NPH) insulins in the treatment of severe diabetes. Diabetes. 1966 Mar;15(3):219–222. doi: 10.2337/diab.15.3.219. [DOI] [PubMed] [Google Scholar]
  47. Olefsky J. M., Kolterman O. G. Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. Am J Med. 1981 Jan;70(1):151–168. doi: 10.1016/0002-9343(81)90422-8. [DOI] [PubMed] [Google Scholar]
  48. Peterson C. M., Forhan S. E., Jones R. L. Self-management: an approach to patients with insulin-dependent diabetes mellitus. Diabetes Care. 1980 Jan-Feb;3(1):82–87. doi: 10.2337/diacare.3.1.82. [DOI] [PubMed] [Google Scholar]
  49. Peterson C. M., Jovanovic L. B., Brownlee M., Jones R. L., Cerami A. Closing the loop: practical and theoretical. Diabetes Care. 1980 Mar-Apr;3(2):318–321. doi: 10.2337/diacare.3.2.318. [DOI] [PubMed] [Google Scholar]
  50. Pettitt D. J., Knowler W. C., Lisse J. R., Bennett P. H. Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians. Lancet. 1980 Nov 15;2(8203):1050–1052. doi: 10.1016/s0140-6736(80)92274-6. [DOI] [PubMed] [Google Scholar]
  51. Pfeifer M. A., Halter J. B., Porte D., Jr Insulin secretion in diabetes mellitus. Am J Med. 1981 Mar;70(3):579–588. doi: 10.1016/0002-9343(81)90579-9. [DOI] [PubMed] [Google Scholar]
  52. Phillips M., Simpson R. W., Holman R. R., Turner R. C. A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements. Q J Med. 1979 Jul;48(191):493–506. [PubMed] [Google Scholar]
  53. Pickup J. C., White M. C., Keen H., Parsons J. A., Alberti K. G. Long-term continuous subcutaneous insulin infusion in diabetics at home. Lancet. 1979 Oct 27;2(8148):870–873. doi: 10.1016/s0140-6736(79)92686-2. [DOI] [PubMed] [Google Scholar]
  54. Porte D., Jr, Robertson R. P. Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system. Fed Proc. 1973 Jul;32(7):1792–1796. [PubMed] [Google Scholar]
  55. RUNYAN J. W., Jr Influence of thiazide diuretics on carbohydrate metabolism in patients with mild diabetes. N Engl J Med. 1962 Sep 13;267:541–543. doi: 10.1056/NEJM196209132671105. [DOI] [PubMed] [Google Scholar]
  56. Raskin P. Treatment of type I diabetes with portable insulin infusion devices. Diabetes Care. 1982 May-Jun;5 (Suppl 1):48–52. [PubMed] [Google Scholar]
  57. Reaven G. M. Insulin-independent diabetes mellitus: metabolic characteristics. Metabolism. 1980 May;29(5):445–454. doi: 10.1016/0026-0495(80)90170-5. [DOI] [PubMed] [Google Scholar]
  58. Reeves M. L., Seigler D. E., Ryan E. A., Skyler J. S. Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. Am J Med. 1982 Apr;72(4):673–680. doi: 10.1016/0002-9343(82)90479-x. [DOI] [PubMed] [Google Scholar]
  59. Riddle M. C. A strategy for chronic disease. Lancet. 1980 Oct 4;2(8197):734–736. doi: 10.1016/s0140-6736(80)91949-2. [DOI] [PubMed] [Google Scholar]
  60. Riddle M. C., Hart J. Hyperglycemia, recognized and unrecognized, as a risk factor for stroke and transient ischemic attacks. Stroke. 1982 May-Jun;13(3):356–359. doi: 10.1161/01.str.13.3.356. [DOI] [PubMed] [Google Scholar]
  61. Rizza R. A., Gerich J. E., Haymond M. W., Westland R. E., Hall L. D., Clemens A. H., Service F. J. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. N Engl J Med. 1980 Dec 4;303(23):1313–1318. doi: 10.1056/NEJM198012043032301. [DOI] [PubMed] [Google Scholar]
  62. Savage P. J., Bennion L. J., Flock E. V., Nagulesparan M., Mott D., Roth J., Unger R. H., Bennett P. H. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus. J Clin Endocrinol Metab. 1979 Jun;48(6):999–1007. doi: 10.1210/jcem-48-6-999. [DOI] [PubMed] [Google Scholar]
  63. Schade D. S., Eaton R. P., Carlson G. A., Bair R. E., Gaona J. I., Jr, Love J. T., Urenda R. S., Spencer W. J. Future therapy of the insulin-dependent diabetic patient--the implantable insulin delivery system. Diabetes Care. 1981 Mar-Apr;4(2):319–324. doi: 10.2337/diacare.4.2.319. [DOI] [PubMed] [Google Scholar]
  64. Schiffrin A., Belmonte M. M. Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin. A one-year prospective study. Diabetes. 1982 Mar;31(3):255–264. doi: 10.2337/diab.31.3.255. [DOI] [PubMed] [Google Scholar]
  65. Schiffrin A., Belmonte M. Combined continuous subcutaneous insulin infusion and multiple subcutaneous injections in type I diabetic patients. Diabetes Care. 1981 Nov-Dec;4(6):595–600. doi: 10.2337/diacare.4.6.595. [DOI] [PubMed] [Google Scholar]
  66. Schmidt M. I., Hadji-Georgopoulos A., Rendell M., Margolis S., Kowarski A. The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation. Diabetes Care. 1981 Nov-Dec;4(6):579–585. doi: 10.2337/diacare.4.6.579. [DOI] [PubMed] [Google Scholar]
  67. Shapiro B., Savage P. J., Lomatch D., Gniadek T., Forbes R., Mitchell R., Hein K., Starr R., Nutter M., Scherdt B. A comparison of accuracy and estimated cost of methods for home blood glucose monitoring. Diabetes Care. 1981 May-Jun;4(3):396–403. doi: 10.2337/diacare.4.3.396. [DOI] [PubMed] [Google Scholar]
  68. Shima K., Tanaka R., Morishita S., Tarui S., Kumahara Y. Studies on the etiology of "brittle diabetes". Relationship between diabetic instability and insulinogenic reserve. Diabetes. 1977 Aug;26(8):717–725. doi: 10.2337/diab.26.8.717. [DOI] [PubMed] [Google Scholar]
  69. Skyler J. S. A plethora of insulins. Diabetes Care. 1980 Sep-Oct;3(5):638–639. [PubMed] [Google Scholar]
  70. Skyler J. S., Skyler D. L., Seigler D. E., O'Sullivan M. J. Algorithms for adjustment of insulin dosage by patients who monitor blood glucose. Diabetes Care. 1981 Mar-Apr;4(2):311–318. doi: 10.2337/diacare.4.2.311. [DOI] [PubMed] [Google Scholar]
  71. Slama G., Garrel D., Tchobroutsky G. Multiple daily insulin injections through subcutaneously implanted needle. Lancet. 1980 May 17;1(8177):1078–1078. doi: 10.1016/s0140-6736(80)91514-7. [DOI] [PubMed] [Google Scholar]
  72. Soeldner J. S. Treatment of diabetes mellitus by devices. Am J Med. 1981 Jan;70(1):183–194. doi: 10.1016/0002-9343(81)90425-3. [DOI] [PubMed] [Google Scholar]
  73. Süsstrunk H., Morell B., Ziegler W. H., Froesch E. R. Insulin absorption from the abdomen and the thigh in healthy subjects during rest and exercise: blood glucose, plasma insulin, growth hormone, adrenaline and noradrenaline levels. Diabetologia. 1982 Mar;22(3):171–174. doi: 10.1007/BF00283747. [DOI] [PubMed] [Google Scholar]
  74. Tamborlane W. V., Sherwin R. S., Genel M., Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979 Mar 15;300(11):573–578. doi: 10.1056/NEJM197903153001101. [DOI] [PubMed] [Google Scholar]
  75. Tantillo J. J., Karam J. H., Burrill K. C., Jones M. A., Grodsky G. M., Forsham P. H. Immunogenicity of "single peak" beef-pork insulin in diabetic subjects. Diabetes. 1974 Apr;23(4):276–281. doi: 10.2337/diab.23.4.276. [DOI] [PubMed] [Google Scholar]
  76. Tattersall R., Gale E. Patient self-monitoring of blood glucose and refinements of conventional insulin treatment. Am J Med. 1981 Jan;70(1):177–182. doi: 10.1016/0002-9343(81)90424-1. [DOI] [PubMed] [Google Scholar]
  77. Tchobroutsky G. Relation of diabetic control to development of microvascular complications. Diabetologia. 1978 Sep;15(3):143–152. doi: 10.1007/BF00421230. [DOI] [PubMed] [Google Scholar]
  78. Teuscher A. Der Platz der "Monkomponent"-Insuline in der Therapie des Diabetes mellitus. Schweiz Med Wochenschr. 1975 Apr 19;105(16):485–494. [PubMed] [Google Scholar]
  79. Turner R. C., McCarthy S. T., Holman R. R., Harris E. Beta-cell function improved by supplementing basal insulin secretion in mild diabetes. Br Med J. 1976 May 22;1(6020):1252–1254. doi: 10.1136/bmj.1.6020.1252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Virella G., Wohltmann H., Sagel J., Lopes-Virella M. F., Kilpatrick M., Phillips C., Colwell J. Soluble immune complexes in patients with diabetes mellitus: detection and pathological significance. Diabetologia. 1981 Sep;21(3):184–191. doi: 10.1007/BF00252652. [DOI] [PubMed] [Google Scholar]
  81. Waldhäusl W., Bratusch-Marrain P., Gasic S., Korn A., Nowotny P. Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man. Diabetologia. 1979 Oct;17(4):221–227. doi: 10.1007/BF01235858. [DOI] [PubMed] [Google Scholar]
  82. Walford S., Allison S. P., Reeves W. G. The effect of insulin antibodies on insulin dose and diabetic control. Diabetologia. 1982 Feb;22(2):106–110. doi: 10.1007/BF00254838. [DOI] [PubMed] [Google Scholar]
  83. Weled B. J., Ball J., Hofeldt F. D. The hypoglycemic hazards of propranolol in diabetic patients: case reports. Mil Med. 1980 Oct;145(10):705–708. [PubMed] [Google Scholar]
  84. Wright A. D., Walsh C. H., Fitzgerald M. G., Malins J. M. Very pure porcine insulin in clinical practice. Br Med J. 1979 Jan 6;1(6155):25–27. doi: 10.1136/bmj.1.6155.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Yue D. K., Turtle J. R. New forms of insulin and their use in the treatment of diabetes. Diabetes. 1977 Apr;26(4):341–345. doi: 10.2337/diab.26.4.341. [DOI] [PubMed] [Google Scholar]
  86. Zinman B., Vranic M., Albisser A. M., Leibel B. S., Marliss E. D. The role of insulin in the metabolic response to exercise in diabetic man. Diabetes. 1979 Jan;28 (Suppl 1):76–81. doi: 10.2337/diab.28.1.s76. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES